Kentucky - Chronic Conditions—diabetes plan: Policy requirement

Area: 
Policy Or Plan Requirements
Policy Type: 
Statute
Summary: 

State law addresses diabetes plan.

Kansas Revised Statutes 158.838 Emergency administration and self-administration of diabetes and seizure disorder medications

(2) (a) Prior to administering any of the medications listed under subsection (1)(a) of this section to a student, the student’s parent or guardian shall:

*1. Provide the school with a written authorization to administer the medication at school;

*2. Provide a written statement from the student’s health care practitioner, which shall contain the following information:

* a. Student’s name;

* b. The name and purpose of the medication;

* c. The prescribed dosage;

* d. The route of administration;

* e. The frequency that the medication may be administered; and

* f. The circumstances under which the medication may be administered; and

*3. Provide the prescribed medication to the school in its unopened, sealed package with the label affixed by the dispensing pharmacy intact.


Kentucky Revised Status 158.838 Emergency administration and self-administration of diabetes and seizure disorder medications

(1) (a) Beginning July 15, 2014, the board of each local public school district and the governing body of each private and parochial school or school district shall have at least one (1) school employee at each school who has met the requirements of KRS 156.502 on duty during the entire school day to administer or assist with the self-administration of the following medication:

    1. Glucagon subcutaneously to students with diabetes who are experiencing hypoglycemia or other conditions noted in the health care practitioner’s written statement under subsection (2)(a)2. of this section;
    1. Insulin subcutaneously, through the insulin delivery method used by the student and at the times and under the conditions noted in the health care practitioner’s written statement under subsection (2)(a)2. of this section; and
    1. A seizure rescue medication or medication prescribed to treat seizure disorder symptoms approved by the United States Food and Drug Administration and any successor agency.

(b) For those assigned the duties under paragraph (a) of this subsection, the training provided under KRS 156.502 shall include instruction in administering:

    1. insulin and glucagon, as well as recognition of the signs and symptoms of hypoglycemia and hyperglycemia and the appropriate steps to be taken to respond to these symptoms;
Policy Links: